"As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin as a solution to the widespread unaffordability of the life-saving hormone that helps the body process or store blood sugar from food. The initiative could provide major financial relief for nearly 3.5 million Californians who have been diagnosed with diabetes, a majority of whom have Type II diabetes - where the body cannot use insulin correctly."
"CalRx aims to be another competitor in the field by introducing a lower-cost alternative - and possibly put "pressure on other manufacturers to lower their prices as well.""
"According to the state and Civica, the suggested retail price is: No more than $30 for a 10mL vial of insulin No more than $55 for a 5-pack of 3 mL pens According to the HCAI spokesperson in an email to KQED, the "out-of-pocket cost may be lower, depending on insurance coverage.""
California partnered with a nonprofit to develop, produce, and sell its own insulin starting in January to address insulin unaffordability. The program targets financial relief for nearly 3.5 million Californians diagnosed with diabetes, most of whom have Type 2. CalRx proposes suggested retail prices capped at $30 for a 10 mL vial and $55 for a five-pack of 3 mL pens, with potential lower out-of-pocket costs depending on insurance. The effort aims to provide a lower-cost alternative and exert pressure on other manufacturers to reduce prices.
Read at Kqed
Unable to calculate read time
Collection
[
|
...
]